KUALA LUMPUR, 3 December 2021 - A Malaysia-China Relations Survey was conducted online across Malaysia from 30 July 2021 to 22 September 2021 by UCSI Poll Research Centre. This survey is a joint project of the Centre for New Inclusive Asia (CNIA) and the China-ASEAN Research Institute of Guangxi University, China, and conducted by UCSI Poll Research Centre.
The survey aims to understand the acceptance level of China-made vaccines by Malaysians. Malaysia and China’s collaboration with each other will be the key factor to overcome the pandemic in the country. A total of 1,667 respondents were surveyed from across Malaysia, of whom 82% were from Peninsular Malaysia and 18% from East Malaysia.
“The result of our survey will help provide the state actors, policymakers as well as opinion leaders with a reasonably good insight of strength and weaknesses, opportunities and challenges in the China-Malaysia bilateral relations,” said Ong Tee Keat, CNIA Chairman.
As the Chief Executive Officer of UCSI Poll Research Centre, Dr Pek Chuen Khee presented the data, he revealed that Malaysians did not have any preference for China-made vaccines. About one-third of the respondents (33.1%) and their family members (32.9%) indicated that they were happy to take China-made vaccines.
The analysis further showed that the acceptance level of China-made vaccines varies with ethnicities. The highest level of acceptance is among Chinese (42.5%) followed by Malay (32.0%), Others (22.1%), and Indian (17.4%). Respondents viewed that the main advantages of China-made vaccines are their affordability and large supply.
The majority of the respondents (75.2%) felt that post-pandemic, there will be improved collaboration opportunities between Malaysia and China. Respondents hoped that Malaysia will attract more investment from China with greater cooperation in e-commerce (54.0%), infrastructure construction (44.7%), tourism (44.5%), electronic products manufacturing (42.4%), and global shared services centers (40.6%).
For more information, contact UCSI University’s Poll Research Centre at (+603) 9101 8880 (ext: 2430/2369) or via email at [email protected]
About UCSI Poll Research Centre The UCSI Poll Research Centre (UCSI-PRC) is a public opinion research company owned by the UCSI Group. Its main objective is to utilise original and scientific research methodologies to investigate and analyse public opinions and attitudes.
Media:Vaccine cooperation improves Malaysians’ perception of China | Tinjauan dapati rakyat Malaysia mahu lihat peningkatan kerjasama dengan China | Tinjauan dapati rakyat Malaysia mahu lihat peningkatan kerjasama dengan China | The Malaysian Insight The Malaysian Insight Sour | Malaysia Aktif | 民调:华裔接受度最高 大马人没偏好中国疫苗 | 民调查询国人疫苗接受程度 仅33.1%乐于接种中国疫苗 | 【新闻线】民调：没偏好中国疫苗 华裔接受度最高 | 国人对中国疫苗看法 民调显示无偏好 | 民調：不同族群不同接受度 國人沒特別偏好中國疫苗 | 民意调查出炉：大马人更偏爱中国疫苗？3剂科兴仍难防Omicron？ |